Leishen Energy Holding Co., Ltd.
LSE Nasdaq Oil & Gas Field Machinery & Equipment Financials FY2022–FY2025
What Leishen Energy Holding Co., Ltd. does
No business description yet.
- Legal name
- Leishen Energy Holding Co., Ltd.
- Fiscal year ends
- September 30, 2025
- Latest annual report
- 20-F · Jan 30, 2026
- Accession · CIK
- 0001493152-26-004368
0001985139
Revenue and margins
Leishen Energy Holding Co., Ltd. had $48.3M of revenue in fiscal 2025, down 30.0% on the year before.
Net income and earnings per share
From fiscal 2022 to 2025, diluted EPS grew −40.0% a year. Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was −$3.7M in fiscal 2025, −7.6% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Leishen Energy Holding Co., Ltd. returned — to shareholders in fiscal 2025. The diluted share count rose 7.6%.
Balance sheet
Cash, debt and the ratios that show how comfortably Leishen Energy Holding Co., Ltd. can carry it.
| Fiscal year end | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|
| Cash and short-term investments | $6.3M | $11.8M | $25.2M | $28.8M |
| Debt incl. finance leases | — | $2.2M | $1.2M | $3.1M |
| Net debt / EBITDA | — | −0.8x | −3.0x | — |
| Debt / equity | — | 0.1x | 0.0x | 0.1x |
| Interest coverage | 192.9x | 174.9x | 132.5x | −23.4x |
| Current ratio | — | 1.8x | 2.3x | 2.5x |
| Quick ratio | — | 1.6x | 2.1x | 2.4x |
| Total assets | — | $65.5M | $69.6M | $69.3M |
| Total liabilities | — | $33.7M | $29.2M | $23.9M |
| Shareholders' equity | $29.6M | $30.8M | $39.8M | $45.4M |
| Net debt (− = net cash) | — | −$9.6M | −$23.9M | −$25.8M |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. “Plan” marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
—
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8–9 is strong, 0–2 weak.
| Test | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|
| Net income is positive | ✓ | ✓ | ✓ | ✓ |
| Cash from operations is positive | ✕ | ✓ | ✓ | ✕ |
| Return on assets rose | — | — | ✕ | ✕ |
| Cash from operations exceeds net income | ✕ | ✕ | ✓ | ✕ |
| Debt fell relative to assets | — | — | ✓ | ✕ |
| Current ratio rose | — | — | ✓ | ✓ |
| Share count didn't rise | — | ✓ | ✓ | ✕ |
| Gross margin rose | — | ✕ | ✕ | ✕ |
| Revenue rose relative to assets | — | — | ✕ | ✕ |
| F-score | — / 3 | — / 5 | 6 / 9 | 2 / 9 |
| Accruals ratio | — | 11.4% | −10.3% | 6.9% |
| Altman Z'' | — | 6.34 | 7.17 | 7.03 |
4 years of figures
Amounts in USD. Hover a ratio’s name for its definition.
| Fiscal year | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|
| Income statement | ||||
| Revenue | $46.7M | $73.1M | $69.1M | $48.3M |
| Gross profit | $13.5M | $18.4M | $16.0M | $8.5M |
| Research and development | — | $0.2M | $0.4M | $0.2M |
| Operating income | $8.2M | $11.9M | $7.6M | −$1.7M |
| Interest expense | $0.0M | $0.1M | $0.1M | $0.1M |
| Pretax income | $7.7M | $12.4M | $8.2M | $0.8M |
| Income tax | $2.0M | $0.7M | $0.2M | −$0.5M |
| Net income | $5.7M | $11.9M | $8.1M | $1.3M |
| Diluted EPS | $0.37 | $0.77 | $0.52 | $0.08 |
| Diluted shares | 0.02B | 0.02B | 0.02B | 0.02B |
| Cash flow | ||||
| Cash from operations | −$4.4M | $4.4M | $15.1M | −$3.5M |
| Capital expenditure | $2.9M | $0.7M | $0.7M | $0.2M |
| Free cash flow | −$7.2M | $3.6M | $14.4M | −$3.7M |
| Depreciation and amortization | $0.3M | $0.4M | $0.5M | $0.5M |
| Balance sheet | ||||
| Cash and short-term investments | $6.3M | $11.8M | $25.2M | $28.8M |
| Total debt | — | $2.2M | $1.2M | $3.1M |
| Current assets | — | $58.8M | $61.7M | $59.1M |
| Current liabilities | — | $31.8M | $27.1M | $23.2M |
| Inventory | — | $7.9M | $5.4M | $3.7M |
| Property and equipment, net | — | $3.8M | $4.1M | $3.5M |
| Intangible assets | — | $0.2M | $0.1M | $0.1M |
| Total assets | — | $65.5M | $69.6M | $69.3M |
| Total liabilities | — | $33.7M | $29.2M | $23.9M |
| Shareholders' equity | $29.6M | $30.8M | $39.8M | $45.4M |
| Margins | ||||
| Gross margin | 29.0% | 25.1% | 23.2% | 17.6% |
| Operating margin | 17.6% | 16.3% | 10.9% | −3.4% |
| EBITDA margin | 18.2% | 16.8% | 11.7% | −2.4% |
| Net margin | 12.2% | 16.2% | 11.7% | 2.6% |
| FCF margin | −15.5% | 5.0% | 20.8% | −7.6% |
| Returns | ||||
| Return on capital | — | 52.7% | 46.5% | −8.5% |
| Return on capital employed | — | 35.4% | 17.8% | −3.6% |
| Return on equity | 19.3% | 39.2% | 22.9% | 2.9% |
| Return on assets | — | 18.1% | 12.0% | 1.8% |
| Return on tangible equity | 19.3% | 38.7% | 20.4% | 2.8% |
| Growth | ||||
| Revenue growth | — | 56.4% | −5.5% | −30.0% |
| Net income growth | — | 107.2% | −31.7% | −84.5% |
| EPS growth | — | 108.1% | −32.5% | −84.6% |
| FCF growth | — | — | 294.4% | −125.7% |
| Share count change | — | 0.0% | 0.0% | 7.6% |
| Financial health | ||||
| Net debt / EBITDA | — | −0.8x | −3.0x | — |
| Debt / equity | — | 0.1x | 0.0x | 0.1x |
| Interest coverage | 192.9x | 174.9x | 132.5x | −23.4x |
| Current ratio | — | 1.8x | 2.3x | 2.5x |
| Quick ratio | — | 1.6x | 2.1x | 2.4x |
| Capital allocation | ||||
| Capex / revenue | 6.1% | 1.0% | 1.0% | 0.4% |
| Quality scores | ||||
| Piotroski F-score | — | — | 6.0 | 2.0 |
| Altman Z'' | — | 6.3 | 7.2 | 7.0 |
| Accruals ratio | — | 11.4% | −10.3% | 6.9% |
Source: SEC EDGAR XBRL filings (CIK 0001985139). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only — not investment advice. Check the original filings before relying on any figure.